Art
J-GLOBAL ID:202002246089152203   Reference number:20A1405670

A Case of Rechallenge of Clozapine after Suspicious Drug Eruption

Clozapineによる薬疹を疑われ中止した後に再投与した治療抵抗性統合失調症の1例
Author (15):
Material:
Volume: 122  Issue:Page: 424-430  Publication year: Jun. 25, 2020 
JST Material Number: Z0692A  ISSN: 0033-2658  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1405670&from=J-GLOBAL&jstjournalNo=Z0692A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for mental disorders 
Substance index (8):
Substance index
Chemical Substance indexed to the Article.
Reference (4):
  • Manu, P., Lapitskaya, Y., Shaikh, A., et al. : Clozapine rechallenge after major adverse effects : clinical guidelines based on 259 cases. Am J Ther, 25 (2) ; e218-e223, 2018
  • ノバルティスファーマ株式会社 : クロザリル患者モニタリングサービス (Clozaril Patient Monitoring Service : CPMS) 運用手順 (http://www.clozaril-tekisei.jp/shared/pdf/cpms_4-2.pdf) (参照 2019-11-12)
  • ノバルティスファーマ株式会社 : クロザリル®錠第8回安全性定期報告書. 2015
  • ノバルティスファーマ株式会社 : クロザリル添付文書 (https://drs-net.novartis.co.jp/dr/products/product/clozaril/document/) (参照 2020-03-11)
Terms in the title (4):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page